{
  "ptid_time": "137_S_0438_2006-04-27",
  "img_path": "/data/qiuhui/data/adni/images/137_S_0438/2006-04-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 66,806 mm³, 42.1% above the reference mean. With a Z-score of 1.22 (88.9th percentile), this represents mild enlargement; hippocampal volume measures 5,479 mm³, 21.4% below the reference mean. With a Z-score of -1.85 (3.2th percentile), this represents moderate atrophy; whole brain volume measures 797,415 mm³, 22.5% below the reference mean. With a Z-score of -2.95 (0.2th percentile), this represents significant atrophy; entorhinal cortex volume measures 3,200 mm³, 19.4% below the reference mean. With a Z-score of -1.27 (10.2th percentile), this represents mild atrophy; fusiform gyrus volume measures 14,503 mm³, 19.7% below the reference mean. With a Z-score of -1.71 (4.4th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 15,137 mm³, 25.0% below the reference mean. With a Z-score of -2.24 (1.3th percentile), this represents significant atrophy. ",
  "text_data": "Age is 81.9 years. Gender is Male. Education: 11 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Endocrine-Metabolic; Renal-Genitourinary; Smoking; Major Surgical Procedures. MMSE: 25.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 884.10 pg/mL (normal ); Total tau: 658.00 pg/mL (profound elevated); Phosphorylated tau: 73.60 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the whole brain and middle temporal gyrus, moderate atrophy in the hippocampus and fusiform gyrus, and mild atrophy in the entorhinal cortex, alongside mild ventricular enlargement. The CSF biomarkers reveal normal Aβ but profoundly elevated T-tau and P-tau, suggesting neurodegeneration without amyloid pathology. The MMSE score of 25 is borderline but not severely impaired.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely non-amyloid, tau-related neurodegeneration, possibly primary age-related tauopathy [PART] or another tauopathy).  \n\n**Confidence:** **Medium** (due to the absence of amyloid pathology, which is atypical for typical Alzheimer’s disease, but the tau elevation and structural atrophy strongly suggest neurodegenerative MCI).",
  "timestamp": "2025-07-26T16:09:56.459104"
}